I disagree . I believe all they need to do show they are non inferior to nuclear scans. With this , and I believe they have established non-inferiority, will have a significant commercial impact on demand for nuclear VQ studies. This low bar, means, the availability of perfusion scans is increased substantially (availability of CT scans) and nuclear med department can focus on higher value scans (VQ scans are very low value and occupy workflow). Not to mention, a "one stop scan" as opposed to multiple different scans.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
-0.015(5.17%) |
Mkt cap ! $128.0M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 29.0¢ | 27.5¢ | $79.13K | 280.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 43829 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 48945 | 3 |
View Market Depth
| Last trade - 11.07am 16/06/2025 (20 minute delay) ? |
| 4DX (ASX) Chart |